NEW ANTIFUNGAL AGENTS

被引：76
作者：
GRAYBILL, JR [1 ]
机构：
[1] AUDIE L MURPHY MEM VET HOSP,DEPT MED,MED SERV 111,SAN ANTONIO,TX 78284
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1989年 / 8卷 / 05期
关键词：
D O I：
10.1007/BF01964056
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：402 / 412
页数：11
相关论文
共 81 条
[1]  
Armstrong D, 1988, Ann N Y Acad Sci, V544, P443, DOI 10.1111/j.1749-6632.1988.tb40442.x
[2]   FLUCONAZOLE PENETRATION INTO CEREBROSPINAL-FLUID - IMPLICATIONS FOR TREATING FUNGAL-INFECTIONS OF THE CENTRAL NERVOUS-SYSTEM [J].
ARNDT, CAS ;
WALSH, TJ ;
MCCULLY, CL ;
BALIS, FM ;
PIZZO, PA ;
POPLACK, DG .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) :178-180
[3]  
BORELLI D, 1987, REV INFECTIOUS DI S1, V9, P57
[4]   KETOCONAZOLE THERAPY FOR ENDEMIC BLASTOMYCOSIS [J].
BRADSHER, RW ;
RICE, DC ;
ABERNATHY, RS .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (06) :872-879
[5]   DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].
BRASS, C ;
GALGIANI, JN ;
BLASCHKE, TF ;
DEFELICE, R ;
OREILLY, RA ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158
[6]   EFFECT OF KETOCONAZOLE ON HEPATIC OXIDATIVE DRUG-METABOLISM [J].
BROWN, MW ;
MALDONADO, AL ;
MEREDITH, CG ;
SPEEG, KV .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) :290-297
[7]  
BRU JP, 1988, REV IBER MICOLOGIA S, V5, P34
[8]  
BUCHSBAUM HW, 1985, COCCIDIOIDOMYCOSIS, P438
[9]   CRYPTOCOCCAL MENINGITIS IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) - SUCCESSFUL TREATMENT WITH FLUCONAZOLE AFTER FAILURE OF AMPHOTERICIN-B [J].
BYRNE, WR ;
WAJSZCZUK, CP .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) :384-385
[10]   HIGH-DOSE KETOCONAZOLE FOR TREATMENT OF FUNGAL-INFECTIONS OF THE CENTRAL NERVOUS-SYSTEM [J].
CRAVEN, PC ;
GRAYBILL, JR ;
JORGENSEN, JH ;
DISMUKES, WE ;
LEVINE, BE .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (02) :160-167
123456789